Preventive Medicine encompasses a wide range of strategies aimed at preventing disease, promoting health, and prolonging life. Vaccination is one of the most powerful tools in preventive medicine, as it helps to protect individuals and populations from infectious diseases by stimulating the immune system to produce a protective response against specific pathogens.
Vaccines work by introducing a harmless form of the pathogen or its components into the body, triggering the immune system to recognize and mount a defense against the infectious agent. This immune response results in the production of antibodies and memory cells that provide long-lasting protection against future infections.
Vaccines have been instrumental in reducing the burden of infectious diseases worldwide, preventing millions of cases of illness, disability, and death each year. Diseases such as smallpox, polio, measles, and tetanus have been either eliminated or significantly controlled through widespread vaccination efforts. In addition to preventing infectious diseases, vaccines also offer other benefits to individuals and society as a whole. They can reduce healthcare costs by preventing expensive medical treatments and hospitalizations associated with vaccine-preventable diseases. They also help to protect vulnerable populations, such as infants, elderly individuals, and those with weakened immune systems, who may be at higher risk of complications from infectious diseases.
Vaccination programs are typically implemented through national or regional immunization schedules, which recommend the timing and doses of vaccines for different age groups and populations. These schedules are based on scientific evidence, epidemiological data, and public health priorities, and are regularly updated to reflect changes in disease prevalence, vaccine effectiveness, and emerging infectious threats. Despite the overwhelming success of vaccination programs, challenges remain in achieving and maintaining high vaccine coverage rates. Vaccine hesitancy, misinformation, and access barriers can all contribute to suboptimal vaccine uptake, leading to outbreaks of vaccine-preventable diseases and undermining public health efforts.
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Prophylactic and Molecular Approaches for Mitigating Human Influenza A Viruses: i. Evaluating influenza Vaccine Effectiveness in the Older population ii. Down-regulation of influenza virus genes with novel siRNA-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations
Ayesha Zahid, Griffith University, Australia
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan